Vascular Biogenics Ltd. VBLT

$ 0.16 -8.77%

Quarterly report 2024-Q2
added 08-14-2024

Vascular Biogenics Ltd. Balance Sheet 2011-2024 | VBLT

Annual Balance Sheet Vascular Biogenics Ltd.

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-19.6 M	-10.7 M	-6.5 M	-28.6 M	-6.69 M	-11.6 M	-7.09 M	-36.8 M	28.7 M	-1.22 M	-
Long Term Debt	263 K	-	1.82 M	-	2.17 M	449 K	-	-	-	-	31 M	-	-
Long Term Debt Current	445 K	361 K	529 K	393 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	2.56 M	3.33 M	4.05 M	2.81 M	2.22 M	86 K	70 K	110 K	31.2 M	130 K	-
Total Current Liabilities	2.74 M	2.01 M	9.93 M	7.46 M	-	-	-	-	-	-	-	-	-
Total Liabilities	4.43 M	7.13 M	12.5 M	10.8 M	12.8 M	7.58 M	9.79 M	4.87 M	4.23 M	3.04 M	35.4 M	2.55 M	-
Deferred Revenue	-	-	658 K	725 K	386 K	290 K	1.05 M	-	-	-	-	-	-
Retained Earnings	-82.3 M	-71 M	-262 M	-232 M	-200 M	-181 M	-165 M	-155 M	-139 M	-127 M	-110 M	-92.4 M	-
Total Assets	19.5 M	5.51 M	64.7 M	41.7 M	48.6 M	60.7 M	65.7 M	47.3 M	39.2 M	38.1 M	11.8 M	15.2 M	-
Cash and Cash Equivalents	11.8 M	1.58 M	22 M	13.2 M	9.44 M	-	-	-	-	-	-	-	-
Book Value	15.1 M	-1.62 M	52.2 M	30.9 M	35.8 M	53.1 M	55.9 M	42.4 M	35 M	35.1 M	-23.6 M	12.7 M	-
Total Shareholders Equity	15.1 M	-37 M	50.6 M	30.9 M	36 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Vascular Biogenics Ltd.

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	224 K	243 K	263 K	-	-	-	-	-	-	1.66 M	1.82 M	1.88 M	1.95 M	1.97 M	2.03 M	-	-	-	99 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	108 K	459 K	477 K	-	-	2.44 M	2.56 M	2.69 M	2.9 M	3.09 M	3.33 M	-	-	-	4.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.82 M	4.05 M	4.43 M	2.6 M	5.41 M	8.21 M	7.21 M	-	-	13.5 M	12.5 M	10.3 M	11.5 M	9.82 M	10.8 M	-	-	-	13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	546 K	658 K	679 K	752 K	713 K	725 K	-	-	-	386 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-91.3 M	-86.1 M	-82.3 M	-299 M	-298 M	-297 M	-294 M	-	-	-273 M	-262 M	-253 M	-246 M	-238 M	-232 M	-	-	-	-208 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	11 M	15.6 M	19.5 M	20.9 M	24.6 M	28.1 M	29.7 M	-	-	56.3 M	64.7 M	61.1 M	67.3 M	47.1 M	41.7 M	-	-	-	49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	4.09 M	8.17 M	11.8 M	20.8 M	1.9 M	26.1 M	17.7 M	18.3 M	15.1 M	13.3 M	22 M	25.3 M	31.7 M	24.2 M	13.2 M	11.6 M	16.7 M	12.9 M	9.44 M	-	-	-	29.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	7.19 M	11.5 M	15.1 M	18.3 M	19.2 M	19.9 M	22.5 M	-	-	42.8 M	52.2 M	50.8 M	55.9 M	37.3 M	30.9 M	-	-	-	36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	7.19 M	11.5 M	15.1 M	18.3 M	-46.4 M	-43.1 M	22.5 M	25.3 M	34.4 M	42.8 M	50.6 M	49.2 M	54.3 M	35.7 M	30.9 M	37.4 M	42.7 M	31.6 M	36 M	-	-	-	53.2 M	-	-	-	56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency